<DOC>
	<DOC>NCT01758562</DOC>
	<brief_summary>Randomized controlled study about the efficacy of the mouth rinse Caphosol in patients with allogeneic stem cell transplantation. 85% of the patients receive a severe oral mucositis due to their treatment. 70 patients will be randomized in the intervention (Caphosol) or in the standard (state-of-the-art) group. Primary endpoint is the duration of the mucositis, secondary endpoints are the occurence of oral mucositis measured with the WHO-scale and the occurence of pain measured with the NRS-scale (Numeric Rating Scale). - Trial with medical device</brief_summary>
	<brief_title>Caphosol® Versus State-of-the-art Mouthcare in Patients With Allogeneic Stem Cell Transplantation: a Randomized Controlled Study About the Efficacy of the Mouth Rinse Caphosol®</brief_title>
	<detailed_description />
	<criteria>Inclusion criteria: Allogeneic stem cell transplantation Male and female patients age 1880 Signed informed consent after information Exclusion criteria: Contraindications due to ethical reasons Unable to read or write Unable to speak or understand the german language Lowsalt diet</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>